September 27, 2021 Life Science Tools M&A, Partnerships

Avantor Announces Global Distribution Agreement with Oxford Nanopore Technologies for Handheld MinION DNA/RNA Sequencer

Partnership will broaden global access for scientists to benefit from portable DNA/RNA sequencing technology that provides rich data in real time, for life science research applications Oxford Nanopore Technologies MinIONTM and MinIONTM Mk1C DNA/RNA Sequencing Devices RADNOR, Pa. (USA) — Sept. 27, 2021 — Avantor, a leading global provider of mission-critical products and services to customers... Read more

May 11, 2021 Licensing, IP, and Legal Life Science Tools

Court of Appeals for the Federal Circuit, US, upholds jury decision to invalidate certain PacBio patents

Tue 11th May 2021 Today the Court of Appeals for the Federal Circuit issued a unanimous Precedential Opinion and Judgment affirming the jury’s March 2020 verdict in the PacBio v. Oxford Nanopore case, that invalidated a number of PacBio patents.  This has been a long running dispute in which Oxford Nanopore has repeatedly prevailed.  In... Read more

May 5, 2021 Life Science Tools Product Launch

Oxford Nanopore provides updated kits and protocols for rapid, scalable and low-cost sequencing of SARS-CoV-2 genomes

Wed 5th May 2021 Oxford Nanopore has released new protocols enabling the rapid, cost effective sequencing of SARS-CoV-2 — the virus that causes COVID-19. Research teams are able to access sequencing technology in days, without capital cost, for quick set-up of rapid turnaround SARS-CoV-2 sequencing.  From initial characterisation of the SARS-CoV-2 virus genome to the rapid identification of variants, researchers have been... Read more

March 25, 2021 Life Science Tools M&A, Partnerships Product Launch

Oxford Nanopore and Circulomics launch kits to enable routine sequencing of ultra-long fragments of DNA

Thu 25th March 2021 Results from developers on human samples — MinION (left) and PromethION (right) The Ultra-Long DNA Sequencing Kit, which has enabled read lengths of up to 4.2 Mb and maximises the quantity of ultra-long fragments, is now available in store. In combination with Circulomics Nanobind Kits, the Oxford Nanopore Ultra-Long DNA Sequencing Kit... Read more

January 12, 2021 Life Science Tools M&A, Partnerships

Oxford Nanopore and NVIDIA collaborate to partner the DGX AI compute system with ultra-high throughput PromethION sequencer

Tue 12th January 2021 Oxford Nanopore Technologies and NVIDIA are collaborating this year to integrate the NVIDIA DGX Station A100 into Oxford Nanopore’s ultra-high throughput sequencing system, PromethION.  Partnering the NVIDIA A100 Tensor Core GPU technology with the PromethION device aims to deliver the world’s most powerful sequencer that supports real-time analyses at scale, and... Read more

December 15, 2020 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Oxford Nanopore and SourceBio announce commercial partnership for UK COVID-19 testing service

Tue 15th December 2020 Oxford Nanopore’s rapid LamPORE COVID-19 test to be made available via SourceBio accredited lab facilities. Oxford Nanopore Technologies Limited (“Oxford Nanopore”), a leading next generation DNA/RNA sequencing technology company and SourceBio International plc (“SourceBio”), an international provider of integrated state of the art laboratory services and products, announce a strategic commercial... Read more

September 16, 2020 Chemicals, Reagents & Kits Life Science Tools Product Launch

Targeted sequencing with Oxford Nanopore: Fast, flexible, PCR-free Cas9 Sequencing Kit now available in store

Wed 16th September 2020 New Cas9 Sequencing Kit provides reagents for one-stop targeted sequencing, enabling scientists to cost-effectively sequence previously inaccessible target regions. Cas9 targeted sequencing with nanopore enables fast, simple, flexible target enrichment of long regions of interest – read lengths of over 100 kb have been observed to date. The approach is amplification-free, opening up regions... Read more

May 26, 2020 Life Science Tools PR/Corporate

Oxford Nanopore announces £48.4M ($59.2M) in new capital to support ongoing innovation and the rapid worldwide growth of nanopore sequencing

Tue 26th May 2020 26th May 2020, Oxford, UK:  Oxford Nanopore Technologies has raised £48.4M ($59.2M) in new capital. The funding comes from new investors and existing shareholders in EMEA, US and Asia, and adds to the £29M of new capital raised in Q4 2019.   Further information on Oxford Nanopore’s fundraising will be made... Read more

May 22, 2020 Life Science Tools Product Launch

Oxford Nanopore Technologies announces advanced development of LamPORE, for rapid, highly scalable, low-cost COVID-19 detection

Fri 22nd May 2020 LamPORE is designed for use in both high-throughput labs or decentralised locations- Oxford Nanopore Technologies is in advanced development of a new generation of end-to-end test (assay) for the detection of SARS-CoV-2, the virus that causes COVID-19. The LamPORE assay is designed to be rapid, low cost, and scalable to cater... Read more